Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A. Issue 1 (11th December 2016) - Ragni, M. V.; Yabes, J. G.; Fogarty, P. F.; Josephson, N. C.; Kessler, C. M.; Neff, A. T.; Raffini, L.; Brummel‐Ziedins, K.; Moore, C. G.